These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8948010)

  • 1. Transgenic and null mutant animals for psychosomatic research.
    Crnic LS
    Psychosom Med; 1996; 58(6):622-32. PubMed ID: 8948010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases.
    Linder CC
    Lab Anim (NY); 2001 May; 30(5):34-9. PubMed ID: 11385732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically engineered mice and their use in aging research.
    Andersen JK
    Mol Biotechnol; 2001 Sep; 19(1):45-57. PubMed ID: 11697220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically modified animals and human medicine.
    Racay P
    Bratisl Lek Listy; 2002; 103(3):121-6. PubMed ID: 12190045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic animal models in biomedical research.
    Houdebine LM
    Methods Mol Biol; 2007; 360():163-202. PubMed ID: 17172731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetically engineered mice and its application to bioindustry].
    Koda T; Togashi Y; Nishimura T
    Hokkaido Igaku Zasshi; 2002 Mar; 77(2):151-6. PubMed ID: 11968850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rebirth of neuroscience in psychosomatic medicine, Part I: historical context, methods, and relevant basic science.
    Lane RD; Waldstein SR; Chesney MA; Jennings JR; Lovallo WR; Kozel PJ; Rose RM; Drossman DA; Schneiderman N; Thayer JF; Cameron OG
    Psychosom Med; 2009 Feb; 71(2):117-34. PubMed ID: 19196808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the tools for creating transgenic animal models of human diseases - focus on atherosclerosis.
    Volobueva AS; Orekhov AN; Deykin AV
    Braz J Med Biol Res; 2019; 52(5):e8108. PubMed ID: 31038578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediation analysis in psychosomatic medicine research.
    Lockhart G; MacKinnon DP; Ohlrich V
    Psychosom Med; 2011 Jan; 73(1):29-43. PubMed ID: 21148809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic and knockout databases: behavioral profiles of mouse mutants.
    Anagnostopoulos AV; Mobraaten LE; Sharp JJ; Davisson MT
    Physiol Behav; 2001 Aug; 73(5):675-89. PubMed ID: 11566202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmatory factor analysis: an introduction for psychosomatic medicine researchers.
    Babyak MA; Green SB
    Psychosom Med; 2010 Jul; 72(6):587-97. PubMed ID: 20467001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-engineered models for genetic manipulation and functional analysis of the cardiovascular system in mice.
    Chu PH; Lu JT; Chen J
    Chang Gung Med J; 2003 Dec; 26(12):868-78. PubMed ID: 15008321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin transgenic and knockout mice: functional analysis and validation of disease-causing mutations.
    Vijayaraj P; Söhl G; Magin TM
    Methods Mol Biol; 2007; 360():203-51. PubMed ID: 17172732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a new assessment strategy in psychosomatic medicine: the diagnostic criteria for psychosomatic research.
    Fabbri S; Fava GA; Sirri L; Wise TN
    Adv Psychosom Med; 2007; 28():1-20. PubMed ID: 17684317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More than the sum of its parts: meta-analysis and its potential to discover sources of heterogeneity in psychosomatic medicine.
    Tak LM; Meijer A; Manoharan A; de Jonge P; Rosmalen JG
    Psychosom Med; 2010 Apr; 72(3):253-65. PubMed ID: 20395625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics in psychosomatic medicine: research designs and statistical approaches.
    McCaffery JM; Snieder H; Dong Y; de Geus E
    Psychosom Med; 2007; 69(2):206-16. PubMed ID: 17289826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of genetically engineered mice as models for understanding human neurodegenerative disease.
    Andersen JK; Jurma OP
    J Am Geriatr Soc; 1996 Jun; 44(6):717-22. PubMed ID: 8642167
    [No Abstract]   [Full Text] [Related]  

  • 18. Research paradigms in psychosomatic medicine with special emphasis on whiplash - cervical hyperextension flexion injury (CHFI).
    Merskey H
    Pain Res Manag; 2003; 8(1):13-8. PubMed ID: 12717472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse genetics in the 21st century: using gene targeting to create a cornucopia of mouse mutants possessing precise genetic modifications.
    Wilder PJ; Rizzino A
    Cytotechnology; 1993; 11(2):79-99. PubMed ID: 7763692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and renal phenotyping of genetically modified mice: a challenge for traditional physiology.
    Fitzgerald SM; Gan L; Wickman A; Bergström G
    Clin Exp Pharmacol Physiol; 2003 Apr; 30(4):207-16. PubMed ID: 12680837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.